These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

154 related articles for article (PubMed ID: 32246351)

  • 1. MR imaging findings of low-grade serous carcinoma of the ovary: comparison with serous borderline tumor.
    Kawaguchi M; Kato H; Hatano Y; Tomita H; Hara A; Suzui N; Miyazaki T; Furui T; Morishige KI; Matsuo M
    Jpn J Radiol; 2020 Aug; 38(8):782-789. PubMed ID: 32246351
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Are CT and MRI useful tools to distinguish between micropapillary type and typical type of ovarian serous borderline tumors?
    Zhang Y; Tan J; Wang J; Ai C; Jin Y; Wang H; Li M; Zhang H; Zhong S
    Abdom Radiol (NY); 2021 Jul; 46(7):3354-3364. PubMed ID: 33660041
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Imaging in gynecological disease (12): clinical and ultrasound features of invasive and non-invasive malignant serous ovarian tumors.
    Moro F; Baima Poma C; Zannoni GF; Vidal Urbinati A; Pasciuto T; Ludovisi M; Moruzzi MC; Carinelli S; Franchi D; Scambia G; Testa AC
    Ultrasound Obstet Gynecol; 2017 Dec; 50(6):788-799. PubMed ID: 28101917
    [TBL] [Abstract][Full Text] [Related]  

  • 4. MRI appearance of ovarian serous borderline tumors of the micropapillary type compared to that of typical ovarian serous borderline tumors: radiologic-pathologic correlation.
    Nakai G; Yamada T; Yamamoto K; Hirose Y; Ohmichi M; Narumi Y
    J Ovarian Res; 2018 Jan; 11(1):7. PubMed ID: 29321056
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Low-grade Serous Carcinoma of the Ovary: Clinicopathologic Analysis of 52 Invasive Cases and Identification of a Possible Noninvasive Intermediate Lesion.
    Ahn G; Folkins AK; McKenney JK; Longacre TA
    Am J Surg Pathol; 2016 Sep; 40(9):1165-76. PubMed ID: 27487741
    [TBL] [Abstract][Full Text] [Related]  

  • 6. BRAF
    Turashvili G; Grisham RN; Chiang S; DeLair DF; Park KJ; Soslow RA; Murali R
    Histopathology; 2018 Sep; 73(3):438-443. PubMed ID: 29770477
    [TBL] [Abstract][Full Text] [Related]  

  • 7. CT Features of Ovarian Tumors: Defining Key Differences Between Serous Borderline Tumors and Low-Grade Serous Carcinomas.
    Nougaret S; Lakhman Y; Molinari N; Feier D; Scelzo C; Vargas HA; Sosa RE; Hricak H; Soslow RA; Grisham RN; Sala E
    AJR Am J Roentgenol; 2018 Apr; 210(4):918-926. PubMed ID: 29489407
    [TBL] [Abstract][Full Text] [Related]  

  • 8. High Frequency of
    Ishibashi T; Nakayama K; Razia S; Ishikawa M; Nakamura K; Yamashita H; Dey P; Iida K; Kurioka H; Nakayama S; Otsuki Y; Ishikawa N; Kyo S
    Diagnostics (Basel); 2019 Dec; 10(1):. PubMed ID: 31892193
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Mutational spectrum in clinically aggressive low-grade serous carcinoma/serous borderline tumors of the ovary-Clinical significance of BRCA2 gene variants in genomically stable tumors.
    Zhang X; Devins K; Ko EM; Reyes MC; Simpkins F; Drapkin R; Schwartz LE; Yoon JY
    Gynecol Oncol; 2021 Jun; 161(3):762-768. PubMed ID: 33773808
    [TBL] [Abstract][Full Text] [Related]  

  • 10. MRI appearances of ovarian serous borderline tumor: pathological correlation.
    Zhao SH; Qiang JW; Zhang GF; Boyko OB; Wang SJ; Cai SQ; Wang L
    J Magn Reson Imaging; 2014 Jul; 40(1):151-6. PubMed ID: 24923479
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Differentiation of Seromucinous Borderline Tumor from Serous Borderline Tumor on MR Imaging.
    Kurata Y; Kido A; Moribata Y; Kameyama K; Minamiguchi S; Konishi I; Togashi K
    Magn Reson Med Sci; 2018 Jul; 17(3):211-217. PubMed ID: 28993546
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Serous borderline tumors of the ovary: a long-term follow-up study of 137 cases, including 18 with a micropapillary pattern and 20 with microinvasion.
    Prat J; De Nictolis M
    Am J Surg Pathol; 2002 Sep; 26(9):1111-28. PubMed ID: 12218568
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Molecular profiling of low grade serous ovarian tumours identifies novel candidate driver genes.
    Hunter SM; Anglesio MS; Ryland GL; Sharma R; Chiew YE; Rowley SM; Doyle MA; Li J; Gilks CB; Moss P; Allan PE; Stephens AN; Huntsman DG; deFazio A; Bowtell DD; ; Gorringe KL; Campbell IG
    Oncotarget; 2015 Nov; 6(35):37663-77. PubMed ID: 26506417
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Clinicopathologic and Molecular Features of Paired Cases of Metachronous Ovarian Serous Borderline Tumor and Subsequent Serous Carcinoma.
    Chui MH; Xing D; Zeppernick F; Wang ZQ; Hannibal CG; Frederiksen K; Kjaer SK; Cope L; Kurman RJ; Shih IM; Wang TL; Vang R
    Am J Surg Pathol; 2019 Nov; 43(11):1462-1472. PubMed ID: 31343420
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Serous surface papillary borderline ovarian tumors: correlation of sonographic features with clinic pathological findings.
    Wang D; Su N; Wang R; Zhang L; Qi Z; Liu Z; Yang J; Leng J; Xiang Y;
    Ultrasound Obstet Gynecol; 2024 May; 63(5):691-698. PubMed ID: 37592848
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Role of magnetic resonance imaging to differentiate between borderline and malignant serous epithelial ovarian tumors.
    Akçay A; Peker AA; Oran Z; Toprak H; Toluk Ö; Balsak S; Badur BA; Gültekin MA
    Abdom Radiol (NY); 2024 Jan; 49(1):229-236. PubMed ID: 37857912
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Stage II to IV low-grade serous carcinoma of the ovary is associated with a poor prognosis: a clinicopathologic study of 32 patients from a population-based tumor registry.
    Ali RH; Kalloger SE; Santos JL; Swenerton KD; Gilks CB
    Int J Gynecol Pathol; 2013 Nov; 32(6):529-35. PubMed ID: 24071867
    [TBL] [Abstract][Full Text] [Related]  

  • 18. KRAS (but not BRAF) mutations in ovarian serous borderline tumour are associated with recurrent low-grade serous carcinoma.
    Tsang YT; Deavers MT; Sun CC; Kwan SY; Kuo E; Malpica A; Mok SC; Gershenson DM; Wong KK
    J Pathol; 2013 Dec; 231(4):449-56. PubMed ID: 24549645
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Apparent diffusion coefficient (ADC) values of serous, endometrioid, and clear cell carcinoma of the ovary: pathological correlation.
    Ono T; Kishimoto K; Tajima S; Maeda I; Takagi M; Suzuki N; Mimura H
    Acta Radiol; 2020 Jul; 61(7):992-1000. PubMed ID: 31698924
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Extraovarian cystadenomas: ultrasound and MR findings in 7 cases.
    Ghossain MA; Braidy CG; Kanso HN; Farah K; Klein-Tomb L; Trak-Smayra V; Suidan JS; Elhage A; Atallah D; Abboud J
    J Comput Assist Tomogr; 2005; 29(1):74-9. PubMed ID: 15665687
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.